Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.

Chen Q, Shi R, Liu W, Jiang D.

PLoS One. 2013 Aug 16;8(8):e72487. doi: 10.1371/journal.pone.0072487. eCollection 2013.

2.

Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.

Wu S, Cai J, Wang H, Zhang H, Yang W.

PLoS One. 2013 Aug 15;8(8):e72526. doi: 10.1371/journal.pone.0072526. eCollection 2013.

3.

Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.

Gu C, Zhou L, Yu J.

PLoS One. 2013 Jul 22;8(7):e66979. doi: 10.1371/journal.pone.0066979. Print 2013.

4.

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.

Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüning T; GENICA Network, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Gantcev SH, Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X; kConFab AOCS Management Group, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton LA, Sherman ME, Lissowska J, Chanock SJ, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Shen CY, Ding SL, Hsu HM, Yu JC, Anton-Culver H, Ziogas A, Ashworth A, Swerdlow A, Jones M, Orr N, Trentham-Dietz A, Egan K, Newcomb P, Titus-Ernstoff L, Easton D, Spurdle AB.

Hum Mol Genet. 2011 Dec 1;20(23):4693-706. doi: 10.1093/hmg/ddr368. Epub 2011 Aug 18.

5.

Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.

Wang X, Zhang L, Chen Z, Ma Y, Zhao Y, Rewuti A, Zhang F, Fu D, Han Y.

PLoS One. 2013 Sep 6;8(9):e73611. doi: 10.1371/journal.pone.0073611. eCollection 2013.

6.

Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.

Huang T, Hong J, Lin W, Yang Q, Ni K, Wu Q, Sun J.

PLoS One. 2013 Aug 16;8(8):e69056. doi: 10.1371/journal.pone.0069056. eCollection 2013.

7.

Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women.

Jiang Y, Shen H, Liu X, Dai J, Jin G, Qin Z, Chen J, Wang S, Wang X, Hu Z, Shen H.

PLoS One. 2011;6(6):e21563. doi: 10.1371/journal.pone.0021563. Epub 2011 Jun 27.

8.

NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.

Fu YP, Edvardsen H, Kaushiva A, Arhancet JP, Howe TM, Kohaar I, Porter-Gill P, Shah A, Landmark-Høyvik H, Fosså SD, Ambs S, Naume B, Børresen-Dale AL, Kristensen VN, Prokunina-Olsson L.

Mol Cancer. 2010 May 19;9:113. doi: 10.1186/1476-4598-9-113.

9.

Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.

Wang H, Yang Z, Zhang H.

Breast Cancer Res Treat. 2013 Jan;137(2):511-22. doi: 10.1007/s10549-012-2343-7. Epub 2012 Nov 27.

PMID:
23184080
10.

A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.

Li T, Zhao J, Yang J, Ma X, Dai Q, Huang H, Wang L, Liu P.

PLoS One. 2016 Apr 12;11(4):e0153314. doi: 10.1371/journal.pone.0153314. eCollection 2016.

11.

Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.

Wu X, Xu QQ, Guo L, Yu CT, Xiong YY, Wei ZY, Huo R, Li ST, Shen L, Niu JM, Liu L, Lin Y, He L, Qin SY.

PLoS One. 2013 Jun 13;8(6):e65206. doi: 10.1371/journal.pone.0065206. Print 2013.

12.

Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.

Yu Y, Chen Z, Wang H, Zhang Y.

PLoS One. 2013 Aug 19;8(8):e72154. doi: 10.1371/journal.pone.0072154. eCollection 2013.

13.

Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.

Chen MB, Li C, Shen WX, Guo YJ, Shen W, Lu PH.

Mol Biol Rep. 2011 Oct;38(7):4687-95. doi: 10.1007/s11033-010-0603-3. Epub 2010 Dec 2.

PMID:
21127985
14.

Association between mitogen-activated protein kinase kinase kinase 1 polymorphisms and breast cancer susceptibility: a meta-analysis of 20 case-control studies.

Zheng Q, Ye J, Wu H, Yu Q, Cao J.

PLoS One. 2014 Mar 4;9(3):e90771. doi: 10.1371/journal.pone.0090771. eCollection 2014.

15.

Association of 8q24 rs13281615A > G polymorphism with breast cancer risk: evidence from 40,762 cases and 50,380 controls.

Dai G, Guo Z, Yang X, Yu B, Li L.

Mol Biol Rep. 2013 Jun;40(6):4065-73. doi: 10.1007/s11033-012-2484-0. Epub 2013 Jan 5.

PMID:
23292077
16.

Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.

Pei J, Li F, Wang B.

Tumour Biol. 2013 Dec;34(6):4073-9. doi: 10.1007/s13277-013-0997-3. Epub 2013 Jul 26.

PMID:
23888322
17.

11q13 is a susceptibility locus for hormone receptor positive breast cancer.

Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, Kerin M, Miller N, Milne RL, Zamora MP, Pérez JI, Benítez J, Hamann U, Ko YD, Brüning T; GENICA Network, Chang-Claude J, Eilber U, Hein R, Nickels S, Flesch-Janys D, Wang-Gohrke S, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Chenevix-Trench G, Beesley J, Chen X; Investigators kConFab; Australian Ovarian Cancer Study Group, Menegaux F, Cordina-Duverger E, Shen CY, Yu JC, Wu PE, Hou MF, Andrulis IL, Selander T, Glendon G, Mulligan AM, Anton-Culver H, Ziogas A, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Jones M, Orr N, Ashworth A, Swerdlow A, Severi G, Baglietto L, Giles G, Southey M, Marmé F, Schneeweiss A, Sohn C, Burwinkel B, Yesilyurt BT, Neven P, Paridaens R, Wildiers H, Brenner H, Müller H, Arndt V, Stegmaier C, Meindl A, Schott S, Bartram CR, Schmutzler RK, Cox A, Brock IW, Elliott G, Cross SS, Fasching PA, Schulz-Wendtland R, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Silva Idos S, Peto J, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Dörk T, Schürmann P, Bremer M, Hillemanns P, Bogdanova NV, Antonenkova NN, Rogov YI, Karstens JH, Khusnutdinova E, Bermisheva M, Prokofieva D, Gancev S, Jakubowska A, Lubinski J, Jaworska K, Durda K, Nordestgaard BG, Bojesen SE, Lanng C, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Radice P, Peterlongo P, Manoukian S, Bernard L, Couch FJ, Olson JE, Wang X, Fredericksen Z, Alnaes GG, Kristensen V, Børresen-Dale AL, Devilee P, Tollenaar RA, Seynaeve CM, Hooning MJ, García-Closas M, Chanock SJ, Lissowska J, Sherman ME, Hall P, Liu J, Czene K, Kang D, Yoo KY, Noh DY, Lindblom A, Margolin S, Dunning AM, Pharoah PD, Easton DF, Guénel P, Brauch H.

Hum Mutat. 2012 Jul;33(7):1123-32. doi: 10.1002/humu.22089. Epub 2012 Apr 30.

18.

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.

Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W, Wang Q.

Breast Cancer Res Treat. 2012 Dec;136(3):885-97. doi: 10.1007/s10549-012-2300-5. Epub 2012 Nov 4. Review.

PMID:
23124475
19.

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, Hankinson SE, Hutchinson A, Wang Z, Yu K, Chatterjee N, Garcia-Closas M, Gonzalez-Bosquet J, Prokunina-Olsson L, Orr N, Willett WC, Colditz GA, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Calle EE, Thun MJ, Diver R, Prentice R, Jackson R, Kooperberg C, Chlebowski R, Lissowska J, Peplonska B, Brinton LA, Sigurdson A, Doody M, Bhatti P, Alexander BH, Buring J, Lee IM, Vatten LJ, Hveem K, Kumle M, Hayes RB, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover RN, Chanock SJ, Hunter DJ.

Nat Genet. 2009 May;41(5):579-84. doi: 10.1038/ng.353. Epub 2009 Mar 29.

20.

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D, Kaaks R, Le Marchand L, Haiman CA, Travis RC, Berg CD, Buring JE, Chanock SJ, Diver WR, Dostal L, Fournier A, Hankinson SE, Henderson BE, Hoover RN, Isaacs C, Johansson M, Kolonel LN, Kraft P, Lee IM, McCarty CA, Overvad K, Panico S, Peeters PH, Riboli E, Sanchez MJ, Schumacher FR, Skeie G, Stram DO, Thun MJ, Trichopoulos D, Zhang S, Ziegler RG, Hunter DJ, Lindström S, Canzian F.

J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63. doi: 10.1093/jnci/djr265. Epub 2011 Jul 26.

Supplemental Content

Support Center